Posts by: Iqra Mumal

News

RegeneRx Biopharmaceuticals announced a clinical trial update on RGN-137, an investigational therapy for the treatment of epidermolysis bullosa (EB). The update was provided by GtreeBNT, RegeneRx’s partner for the ... Read more

October 29, 2018October 29, 2018

FDA Advises Fibrocell on Phase 3 Trial Design for FCX-007, Potential RDEB Therapy

News

Fibrocell Science has completed a type C meeting with the U.S. Food and Drug Administration in which they discussed the design of a Phase 3 clinical trial to assess the ... Read more

September 5, 2018September 5, 2018

2 EB Research Groups Based Continents Apart Partner to Advance New Treatments

News

New York-based EB Research Partnership (EBRP), along with the EB Research Foundation in Australia, announced a global collaboration that aims to develop lifesaving treatments for patients with epidermolysis bullosa (EB). Under the ... Read more

June 18, 2018June 18, 2018

Allogeneic Fibroblast Injections into Skin Lesions Are Safe, Effective for RDEB, Study Shows

News

Allogeneic fibroblast injections are an effective and safe treatment strategy for non-healing wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB), new research from Russia shows. The study, “Allogeneic ... Read more

May 7, 2018May 7, 2018

Epidermolysis Bullosa Can Contribute to Esophageal Stenosis, Case Study Finds

News

Epidermolysis bullosa (EB) can affect the gastrointestinal tract, leading to the development of esophageal stenosis, or a narrowing of the esophagus, according to a new case report. The report, ... Read more

April 4, 2018April 4, 2018

EBA Can Lead to Acute Renal Failure, Case Report Contends

News

Patients with epidermolysis bullosa acquisita sometimes can develop acute renal failure, according to a case report. The report, “Acute renal failure in a patient with epidermolysis bullosa acquisita,” was ... Read more

April 2, 2018April 2, 2018

SYK Protein a Key Regulator of Inflammatory Response in EBA Mouse Model, Study Finds

News

A protein called SYK is a major regulator of the inflammatory response carried out by myeloid cells in mouse models of epidermolysis bullosa acquisita (EBA), showing potential for a ... Read more

February 5, 2018February 5, 2018

Study Finds New Gene Mutation Leading to Recessive Dystrophic Epidermolysis Bullosa

News

Japanese physicians have reported a newly discovered mutation in the COL7A1 gene, called c.6885_6898del14, which resulted in the development of recessive dystrophic epidermolysis bullosa (RDEB) in a child. The ... Read more

December 19, 2017December 19, 2017

Mutation in JUP Gene Can Cause Lethal Congenital EB, Case Report Shows

News

A case report demonstrates that a novel mutation discovered in the junctional plakoglobin (JUP) gene can lead to lethal congenital epidermolysis bullosa (EB). The report, titled “A Novel Mutation ... Read more

September 12, 2017September 12, 2017

CRISPR/Cas9 RNP System Shown to Be Effective for Gene Editing in Epidermolysis Bullosa Mice

News

Researchers have successfully applied the CRISPR/Cas9 system in a mouse model of recessive dystrophic epidermolysis bullosa (RDEB) to restore collagen VII protein function, a new study shows. RDEB is caused ... Read more

Posts by: Iqra Mumal

Iqra Mumal

RegeneRX, GtreeBNT Provide Update on RGN-137 for Treatment of Epidermolysis Bullosa

FDA Advises Fibrocell on Phase 3 Trial Design for FCX-007, Potential RDEB Therapy

2 EB Research Groups Based Continents Apart Partner to Advance New Treatments

Allogeneic Fibroblast Injections into Skin Lesions Are Safe, Effective for RDEB, Study Shows

Epidermolysis Bullosa Can Contribute to Esophageal Stenosis, Case Study Finds

EBA Can Lead to Acute Renal Failure, Case Report Contends

SYK Protein a Key Regulator of Inflammatory Response in EBA Mouse Model, Study Finds

Study Finds New Gene Mutation Leading to Recessive Dystrophic Epidermolysis Bullosa

Mutation in JUP Gene Can Cause Lethal Congenital EB, Case Report Shows

CRISPR/Cas9 RNP System Shown to Be Effective for Gene Editing in Epidermolysis Bullosa Mice

Pin It on Pinterest